Stocks making the major moves premarket: AMD, Levi Strauss, DraftKings and much more

Stocks making the major moves premarket: AMD, Levi Strauss, DraftKings and much more


In this short article

  • AMD
  • CVS
  • DKNG
  • AMBC
  • CSG.N-CH
News Update – Pre-Markets

Video1:1901:19
Information Update – Pre-Marketplaces
News Briefing

In this article are the organizations that are producing headlines prior to the bell:

Superior Micro Products (AMD) – AMD slid 5.3% in the premarket just after chopping its product sales forecast. The chipmaker mentioned it is remaining strike by a larger sized than anticipated slump in the particular computer system market place.

Levi Strauss (LEVI) – Levi Strauss took a 5.3% premarket hit following reducing its complete-12 months gross sales and revenue outlook. The attire maker is observing an affect from bigger fees, offer chain difficulties and a more powerful U.S. greenback.

CVS Health (CVS) – CVS shares fell 5% in premarket investing, following a downgrade of a person of its Aetna Medicare Edge options in yearly scores issued by the Facilities for Medicare and Medicaid Services.

DraftKings (DKNG) – DraftKings rallied 5.6% in premarket motion immediately after Bloomberg noted that the sports activities betting business is shut to putting a main new partnership with Walt Disney‘s (DIS) ESPN unit.

Lyft (LYFT) – Lyft fell 2.6% in the premarket immediately after RBC downgraded the experience-hailing service’s stock to “sector accomplish” from “outperform.” RBC explained its driver offer evaluation points to a considerably less bullish outlook for Lyft and that competitor Uber (UBER) enjoys “structural strengths” more than Lyft.

Ambac (AMBC) – The municipal bond insurer will obtain $1.84 billion to settle lawsuits towards Lender of America (BAC). The fits stemmed from bond insurance policies that Ambac had offered to Financial institution of America’s Countrywide Credit unit prior to the 2008 financial crisis. Ambac surged 21.1% in the premarket.

Credit history Suisse (CS) – Credit Suisse rallied 5.6% in the premarket immediately after the lender claimed it would get back again up to $3 billion in debt as it seeks to reassure buyers of its economic wellness.

Tilray (TLRY) – The cannabis producer jumped 5.4% in premarket investing even as it described a more substantial than envisioned decline as perfectly as a bit decreased than predicted earnings for its most up-to-date quarter. Tilray did reaffirm its whole-yr forecast and mentioned it had achieved approximately all of its charge-preserving objective. Tilray, Aurora Hashish (ACB), Cover Growth Corp (CGC) and Cronos Team (CRON) have been among the hashish stocks that rallied Thursday soon after President Joe Biden declared pardons for those convicted of federal cannabis possession rates.



Supply

Robinhood is rolling out NFL parlay and prop bets on prediction markets platform
Finance

Robinhood is rolling out NFL parlay and prop bets on prediction markets platform

Key Points Robinhood announced a number of prediction markets features on Tuesday. Users are now able to trade what are essentially parlay and prop bets on NFL games and players. The company also said users will be able to combine up to 10 outcomes across NFL games in custom combos, a feature that is expected […]

Read More
Kevin Warsh moves ahead in Fed chief race on Kalshi after Hassett pushback
Finance

Kevin Warsh moves ahead in Fed chief race on Kalshi after Hassett pushback

Kevin Hassett, director of the National Economic Council (L), and Kevin Warsh, former governor of the U.S. Federal Reserve. Reuters Kevin Warsh has surged ahead of Kevin Hassett in prediction markets betting on who President Donald Trump will nominate as the next chair of the Federal Reserve, as doubts grow inside Trump’s orbit about Hassett’s […]

Read More
Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more
Finance

Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more

Check out the companies making headlines before the bell: Pfizer — The pharma giant issued disappointing 2026 earnings guidance. Pfizer a profit between $2.80 per share and $3 per share for the coming year. Analysts polled by LSEG expected earnings per share of $3.05 for 2026. The company also reaffirmed its 2025 outlook. Shares hovered […]

Read More